Följ
Saeed Alipour Parsa
Saeed Alipour Parsa
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences
Verifierad e-postadress på sbmu.ac.ir
Titel
Citeras av
Citeras av
År
Effect of taurine supplementation on exercise capacity of patients with heart failure
MR Beyranvand, MK Khalafi, VD Roshan, S Choobineh, SA Parsa, ...
Journal of cardiology 57 (3), 333-337, 2011
1162011
The association between exposure to air pollutants including PM10, PM2. 5, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide concentration and the relative risk of …
MA Akbarzadeh, I Khaheshi, A Sharifi, N Yousefi, M Naderian, ...
Environmental research 161, 299-303, 2018
642018
MiRNA-Related Polymorphisms in miR-146a and TCF21 Are Associated with Increased Susceptibility to Coronary Artery Disease in an Iranian Population
M Bastami, SMH Ghaderian, MD Omrani, R Mirfakhraie, H Vakili, ...
Genetic testing and molecular biomarkers 20 (5), 241-248, 2016
512016
Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study
SK Hosseini, F Masoudkabir, A Vasheghani-Farahani, S Alipour-Parsa, ...
Planta medica 77 (17), 1870-1875, 2011
512011
Expression pattern of miR-21, miR-25 and PTEN in peripheral blood mononuclear cells of patients with significant or insignificant coronary stenosis
SZ Vahed, SH Aghaee-Bakhtiari, A Daraei, Z Saadatian, HS Kafil, ...
Gene 698, 170-178, 2019
372019
The quality of life after first acute myocardial infarction
MR Beyranvand, A Lorvand, PS ALIPOUR, MR Motamedi, AA Kolahi
RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH) 15 (678), 264-272, 2011
372011
Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus
N Sohrabifar, SMH Ghaderian, S Alipour Parsa, H Ghaedi, H Jafari
Archives of physiology and biochemistry 128 (5), 1308-1315, 2022
272022
Management of ST‐segment‐elevation myocardial infarction during the coronavirus disease 2019 (COVID‐19) outbreak: Iranian “247” National Committee's position paper on primary …
P Sadeghipour, AH Talasaz, V Eslami, B Geraiely, M Vojdanparast, ...
Catheterization and Cardiovascular Interventions 97 (3), E346-E351, 2021
262021
Dysregulated expression of STAT1, miR‐150, and miR‐223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosis
Z Saadatian, Z Nariman‐Saleh‐Fam, M Bastami, Y Mansoori, I Khaheshi, ...
Journal of cellular biochemistry 120 (12), 19810-19824, 2019
222019
The no-reflow phenomenon: is it predictable by demographic factors and routine laboratory data?
M Namazi, E Mahmoudi, M Safi, Y Jenab, H Vakili, H Saadat, SA Parsa, ...
Acta Bio Medica: Atenei Parmensis 92 (5), 2021
202021
Changes of left ventricular mass index among end-stage renal disease patients after renal transplantation
MH Namazi, SA Parsa, B Hosseini, H Saadat, M Safi, MR Motamedi, ...
Urology Journal 7 (2), 105-109, 2010
192010
Is it necessary to discontinue metformin in diabetic patients with GFR> 60 ml/min per 1.73 m2 undergoing coronary angiography: A controversy still exists?
MH Namazi, SA Parsa, K Roohigilani, M Safi, H Vakili, I Khaheshi, ...
Acta Bio Medica: Atenei Parmensis 89 (2), 227, 2018
172018
Effect of a nut-enriched low-calorie diet on body weight and selected markers of inflammation in overweight and obese stable coronary artery disease patients: a randomized …
M Ghanavati, SM Hosseinabadi, SA Parsa, M Safi, H Emamat, ...
European journal of clinical nutrition 75 (7), 1099-1108, 2021
162021
Dysregulation of autophagy-related lncRNAs in peripheral blood of coronary artery disease patients
N Ebadi, S Ghafouri-Fard, M Taheri, S Arsang-Jang, SA Parsa, ...
European journal of pharmacology 867, 172852, 2020
152020
Rest 2D speckle tracking echocardiography may be a sensitive but nonspecific test for detection of significant coronary artery disease
MP Mahjoob, SA Parsa, A Mazarei, M Safi, I Khaheshi, S Esmaeeli
Acta Bio Medica: Atenei Parmensis 88 (4), 457, 2017
152017
Evaluation of pentraxin-3 level and its related factors in patients undergoing primary percutaneous coronary intervention
S Alipour-Parsa, H Haybar, MH Namazi, M Safi, I Khaheshi, M Memaryan, ...
ARYA atherosclerosis 13 (2), 73, 2017
122017
Percutaneous mitral valvuloplasty—a new method for balloon sizing based on maximal commissural diameter to improve procedural results
HR Sanati, M Kiavar, N Salehi, F Shakerian, A Firoozi, SA Parsa, ...
Am Heart Hosp J 8 (1), 29-32, 2010
112010
Serum troponin I level for diagnosis of acute coronary syndrome in patients with chronic kidney disease
MJ Fesharaki, SA Parsa, M Nafar, M Ghaffari-Rahbar, F Omidi, ...
Iranian journal of kidney diseases 10 (1), 11-16, 2016
92016
Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
M Taherioun, MH Namazi, M Safi, H Saadat, H Vakili, S Alipour-Parsa, ...
ARYA atherosclerosis 10 (1), 13, 2014
92014
The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography
TF Langroudi, H Haybar, SA Parsa, M Mahjoorian, I Khaheshi, ...
Romanian Journal of Internal Medicine 56 (3), 167-172, 2018
82018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20